The Montreal Cognitive Assessment (MoCA) is a 30-point, clinician-administered screen for mild cognitive impairment (MCI). In roughly ten minutes it samples eight cognitive domains: short-term memory recall, visuospatial ability (clock drawing, cube copy), executive function (trail-making, verbal fluency, abstraction), attention and working memory, language, and orientation to time and place. It was designed specifically to catch the milder deficits that slip past general cognitive screens.
The MoCA is a screening instrument, not a diagnostic one. A low score signals that a fuller assessment is warranted - history, informant account, functional assessment and, where indicated, formal neuropsychological testing. It does not distinguish between causes of impairment, and a single administration says nothing about trajectory.
02 - Origin & purpose
Where it comes from.
Ziad Nasreddine and colleagues in Montreal published the MoCA in 2005, built for a specific gap: patients with genuine mild cognitive impairment routinely scored in the normal range on the MMSE. In the original validation study of 277 participants (90 healthy controls, 94 with MCI, 93 with mild Alzheimer's disease), the MoCA detected 90% of MCI cases against the MMSE's 18% at conventional cutoffs.
Since then it has become one of the most widely used cognitive screens worldwide, translated into dozens of languages with variants for blind users (MoCA-Blind), lower education (MoCA-Basic) and rapid triage (MoCA 5-min). In September 2019 the copyright holder, MoCA Test Inc., introduced mandatory training and certification (roughly one hour, US$125, renewed every two years, free for students, academic researchers and some publicly operated health institutions since 2021); from September 2020 access to the test materials has been restricted to certified raters. That decision drew published criticism and is the reason we cannot host the instrument here.
03 - Scoring & cutoffs
How scoring works.
Scores range 0-30; 26 and above was defined as normal in the original study, with one point added for 12 or fewer years of education. Points come from: visuospatial/executive (5), naming (3), attention (6), language (3), abstraction (2), delayed recall (5), orientation (6).
The original cutoff of 26 is now known to over-diagnose. At <26 a large re-examination found sensitivity of 93.7% but specificity of only 58.8% - four in ten cognitively normal older adults screen positive. A cutoff of <23 lowers the false-positive rate substantially (specificity around 83-91% across studies) at some cost to sensitivity, and a 2023 meta-analysis supports 23 as the better balance in most settings. Whichever cutoff is used, education, age, language and culture all shift scores, and the result should be interpreted alongside, never instead of, clinical assessment.
04 - Validation evidence
How well it performs.
In the original 2005 validation the MoCA detected 90% of MCI cases at a cutoff of <26, with 87% specificity in healthy elderly controls. Later community samples found specificity at that cutoff to be far lower: a re-examination of cutoff scores reported 93.7% sensitivity but only 58.8% specificity (Carson 2018), meaning roughly four in ten cognitively normal older adults screen positive.
A meta-analysis of 66 studies (Islam 2023) reported approximately 94% sensitivity and 60% specificity at a threshold of >=26, against 73% sensitivity and 83% specificity at >=23 - which is why 23 is now widely preferred. Internal consistency is high (Cronbach's alpha 0.83) and test-retest reliability over a mean 35-day interval was 0.92 in the original study.
90%
SENSITIVITY, MCI (<26)
87%
SPECIFICITY, CONTROLS (<26)
0.83
CRONBACH'S α
0.92
TEST–RETEST, 35 D
05 - How it compares
How it compares to the alternatives.
Instrument
Items
Time
When to reach for it
MoCA
30
~10 min
Clinician-administered 30-point screen for mild cognitive impairment across eight domains. Licensed: certified raters only.
Asks a relative about change rather than testing the patient. Useful when testing is impractical or education/language confounds loom.
GPCOG
patient + informant
~6 min
Designed for general practice; the informant section reduces education and language effects.
06 - When to use it
Right tool, wrong tool.
Reach for it when
-Screening for mild cognitive impairment where sensitivity matters more than specificity.
-Tracking cognition in Parkinson's disease, stroke, heart failure and other conditions with validated MoCA literatures.
-Settings where the examiner is MoCA-certified.
Reach for something else when
-The examiner is not MoCA-certified - use SLUMS or Mini-Cog.
-You need to diagnose dementia; that requires a full assessment.
-Very low education or a non-validated language - consider MoCA-Basic or informant tools such as AD8.
-Repeated testing at short intervals without alternate forms, because of practice effects.
07 - Confidence & precision
Reading the score with care.
A single MoCA point is not a meaningful change. Stroke-rehabilitation studies estimate the minimal clinically important difference at roughly 1.2-2 points, but the minimal detectable change - the difference needed to be confident it is not measurement noise - is around 4-5 points. Treat movements of 1-3 points across visits as within the instrument's error band, and use alternate versions (7.1/7.2/7.3) for repeat testing.
08 - Limitations
What it cannot tell you.
Over-diagnosis at the original cutoff of 26 in older and less-educated people. Strong education, language and culture effects, with norms drawn largely from Western clinic samples. Mandatory paid certification restricts who may administer it. Practice effects appear on repeat testing. It is not validated as a standalone diagnostic instrument, and telephone or remote variants score differently and are not interchangeable with the standard form.
09 - Licensing, explained
How licensing works.
The MoCA is copyrighted by MoCA Test Inc. and, since September 2019, requires paid training and certification (roughly one hour, US$125, renewed every two years; free for students, academic researchers and some publicly operated health institutions since 2021). Test materials have been restricted to certified raters since September 2020, so we cannot host the instrument here. Use the free alternatives instead: SLUMS, Mini-Cog and the informant-based AD8.
See how Aisel removes friction where it costs most. A 20-minute walkthrough tailored to your clinic.
We value your privacy
We use cookies to analyse site usage and improve your experience. Analytics and embedded media (e.g. YouTube) only load if you accept. Read our cookie policy.